BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen JX, Youhanna S, Zandi Shafagh R, Kele J, Lauschke VM. Organotypic and Microphysiological Models of Liver, Gut, and Kidney for Studies of Drug Metabolism, Pharmacokinetics, and Toxicity. Chem Res Toxicol 2020;33:38-60. [DOI: 10.1021/acs.chemrestox.9b00245] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Taebnia N, Römling U, Lauschke VM. In vitro and ex vivo modeling of enteric bacterial infections. Gut Microbes 2023;15:2158034. [PMID: 36576310 DOI: 10.1080/19490976.2022.2158034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Griffin KH, Fok SW, Kent Leach J. Strategies to capitalize on cell spheroid therapeutic potential for tissue repair and disease modeling. NPJ Regen Med 2022;7:70. [PMID: 36494368 DOI: 10.1038/s41536-022-00266-z] [Reference Citation Analysis]
3 Jing B, Yan L, Li J, Luo P, Ai X, Tu P. Functional Evaluation and Nephrotoxicity Assessment of Human Renal Proximal Tubule Cells on a Chip. Biosensors 2022;12:718. [DOI: 10.3390/bios12090718] [Reference Citation Analysis]
4 Bussooa A, Tubbs E, Revol-cavalier F, Chmayssem A, Alessio M, Cosnier M, Verplanck N. Real-time monitoring of oxygen levels within thermoplastic Organ-on-Chip devices. Biosensors and Bioelectronics: X 2022;11:100198. [DOI: 10.1016/j.biosx.2022.100198] [Reference Citation Analysis]
5 Kemas AM, Lauschke VM. Measuring Glucose Consumption and Gluconeogenesis in 3D Human Tissue Cultures with Nanoliter Input Volumes. Autophagy and Cancer 2022. [DOI: 10.1007/978-1-0716-2071-7_21] [Reference Citation Analysis]
6 Winkler TE, Herland A. Sorption of Neuropsychopharmaca in Microfluidic Materials for In Vitro Studies. ACS Appl Mater Interfaces 2021;13:45161-74. [PMID: 34528803 DOI: 10.1021/acsami.1c07639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kemas AM, Youhanna S, Zandi Shafagh R, Lauschke VM. Insulin-dependent glucose consumption dynamics in 3D primary human liver cultures measured by a sensitive and specific glucose sensor with nanoliter input volume. FASEB J 2021;35:e21305. [PMID: 33566368 DOI: 10.1096/fj.202001989RR] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
8 Fransen MFJ, Addario G, Bouten CVC, Halary F, Moroni L, Mota C. Bioprinting of kidney in vitro models: cells, biomaterials, and manufacturing techniques. Essays Biochem 2021:EBC20200158. [PMID: 34096573 DOI: 10.1042/EBC20200158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Naik A, Misra SK. Modern Sensing Approaches for Predicting Toxicological Responses of Food- and Drug-Based Bioactives on Microbiomes of Gut Origin. J Agric Food Chem 2021;69:6396-413. [PMID: 34081444 DOI: 10.1021/acs.jafc.1c02736] [Reference Citation Analysis]
10 Winkler TE, Herland A. Sorption of neuropsychopharmaca in microfluidic materials for in-vitro studies.. [DOI: 10.1101/2021.05.26.445264] [Reference Citation Analysis]
11 Yadav J, El Hassani M, Sodhi J, Lauschke VM, Hartman JH, Russell LE. Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data. Drug Metab Rev 2021;53:207-33. [PMID: 33989099 DOI: 10.1080/03602532.2021.1922435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Youhanna S, Wright SC, Lauschke VM. Organotypic human ex vivo models for coronavirus disease 2019 research and drug development. Curr Opin Pharmacol 2021;59:11-8. [PMID: 34029832 DOI: 10.1016/j.coph.2021.04.006] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Ingelman-Sundberg M, Lauschke VM. 3D human liver spheroids for translational pharmacology and toxicology. Basic Clin Pharmacol Toxicol 2021. [PMID: 33872466 DOI: 10.1111/bcpt.13587] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Gough A, Soto-Gutierrez A, Vernetti L, Ebrahimkhani MR, Stern AM, Taylor DL. Human biomimetic liver microphysiology systems in drug development and precision medicine. Nat Rev Gastroenterol Hepatol 2021;18:252-68. [PMID: 33335282 DOI: 10.1038/s41575-020-00386-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
15 Dufau J, Shen JX, Couchet M, De Castro Barbosa T, Mejhert N, Massier L, Griseti E, Mouisel E, Amri EZ, Lauschke VM, Rydén M, Langin D. In vitro and ex vivo models of adipocytes. Am J Physiol Cell Physiol 2021;320:C822-41. [PMID: 33439778 DOI: 10.1152/ajpcell.00519.2020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
16 Martin F, Titz B, Frentzel S, Schlage WK, Ivanov NV, Hoeng J, Peitsch MC. Translational Models for ENDP Assessment. Toxicological Evaluation of Electronic Nicotine Delivery Products 2021. [DOI: 10.1016/b978-0-12-820490-0.00010-9] [Reference Citation Analysis]
17 Campbell SB, Wu Q, Yazbeck J, Liu C, Okhovatian S, Radisic M. Beyond Polydimethylsiloxane: Alternative Materials for Fabrication of Organ-on-a-Chip Devices and Microphysiological Systems. ACS Biomater Sci Eng 2021;7:2880-99. [PMID: 34275293 DOI: 10.1021/acsbiomaterials.0c00640] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 21.0] [Reference Citation Analysis]
18 Youhanna S, Lauschke VM. The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption Studies. J Pharm Sci 2021;110:50-65. [PMID: 32628951 DOI: 10.1016/j.xphs.2020.07.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
19 Xie R, Korolj A, Liu C, Song X, Lu RXZ, Zhang B, Ramachandran A, Liang Q, Radisic M. h-FIBER: Microfluidic Topographical Hollow Fiber for Studies of Glomerular Filtration Barrier. ACS Cent Sci 2020;6:903-12. [PMID: 32607437 DOI: 10.1021/acscentsci.9b01097] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
20 He Y, Nie J, Xie M, Gao Q. Why choose 3D bioprinting? Part III: printing in vitro 3D models for drug screening. Bio-des Manuf 2020;3:160-3. [DOI: 10.1007/s42242-020-00067-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]